《Lancet,3月16日,Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-03-17
  • Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel

    Gianluca Ianiro,Benjamin H Mullish,Colleen R Kelly,Harry Sokol,Zain Kassam,Siew Ng

    Published:March 16, 2020DOI:https://doi.org/10.1016/S2468-1253(20)30082-0

    As the outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread from China to other countries, governments and the medical community are taking steps to prevent transmission, from common sense recommendations to radical quarantine measures.1

  • 原文来源:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30082-0/fulltext
相关报告
  • 《LANCET,3月20日,Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-04-01
    • Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward Christopher A Green, Mohammed N Quraishi, Sahida Shabir, Naveen Sharma, Richard Hansen, Daniel R Gaya, et al. Show all authors Published:March 30, 2020DOI:https://doi.org/10.1016/S2468-1253(20)30089-3 We thank Gianluca Ianiro and colleagues for highlighting an important concern faced by faecal microbiota transplant (FMT) stakeholders, including stool banks, regulators, and especially recipients, during the current coronavirus disease 2019 (COVID-19) pandemic. The authors are right in highlighting the concern arising from the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in stool samples and the safety implications for FMT donor screening policies. However, we strongly believe that the approach taken by the authors in excluding donors on the basis of having developed COVID-19 symptoms, having had contact with patients with confirmed COVID-19 disease, or having recently travelled to regions affected by COVID-19, is insufficient and potentially unsafe. The world is currently amid a global pandemic, exacerbated by a large burden of asymptomatic or mild cases; as of March 19, 2020, more than 80?000 known cases have been reported in Europe and the UK.
  • 《LANCET,4月3日,Preparing African anticancer centres in the COVID-19 outbreak》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-04-04
    • Preparing African anticancer centres in the COVID-19 outbreak Amine Souadka,Amine Benkabbou,Brahim Al Ahmadi,Saber Boutayeb,Mohammed,Anass Majbar Published:April 03, 2020DOI:https://doi.org/10.1016/S1470-2045(20)30216-3 We congratulate Wenhua Liang and colleagues for their Comment laying out the strategic policies against cancer during the COVID-19 outbreak.1 The disease is now spreading rapidly to and within Africa. Like other countries, Morocco had the opportunity to analyse early COVID-19 data and acknowledge that individual-scale policies such as isolation would not stop the pandemic. Morocco adopted large-scale drastic measures early, including constraining mobility with a mandatory restrictive housing and curfew, despite the low number of cases (starting from 60 cases) compared with Europe. We expect that COVID-19 will have a major impact on African countries, with the risk of a rapid health-care system shutdown, due to a pre-existing shortage in material (eg, intensive-care unit beds or protective equipment) and human resources.